Integral Health Asset Management LLC Invests $22.45 Million in CVS Health Co. (NYSE:CVS)

Integral Health Asset Management LLC acquired a new position in shares of CVS Health Co. (NYSE:CVS) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 500,000 shares of the pharmacy operator’s stock, valued at approximately $22,445,000. CVS Health accounts for approximately 1.9% of Integral Health Asset Management LLC’s investment portfolio, making the stock its 13th biggest position.

A number of other hedge funds and other institutional investors have also made changes to their positions in CVS. Whitebox Advisors LLC purchased a new position in shares of CVS Health during the 4th quarter valued at approximately $249,000. Hall Laurie J Trustee lifted its position in shares of CVS Health by 25,484.4% during the 4th quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator’s stock valued at $517,000 after buying an additional 11,468 shares in the last quarter. B&D White Capital Company LLC purchased a new position in shares of CVS Health during the 4th quarter valued at approximately $417,000. Seizert Capital Partners LLC lifted its position in shares of CVS Health by 22.8% during the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator’s stock valued at $25,566,000 after buying an additional 105,708 shares in the last quarter. Finally, M.E. Allison & CO. Inc. purchased a new position in shares of CVS Health during the 4th quarter valued at approximately $277,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity

In other news, Director Michael F. Mahoney bought 30,000 shares of the stock in a transaction on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of the business’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23% decrease in their position. The disclosure for this sale can be found here. 1.22% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Royal Bank of Canada raised their price objective on CVS Health from $74.00 to $81.00 and gave the company an “outperform” rating in a report on Monday, May 5th. StockNews.com raised CVS Health from a “hold” rating to a “buy” rating in a research note on Friday. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $84.00 target price (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Mizuho raised their target price on CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Finally, Wolfe Research raised their target price on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $74.81.

CVS Health Trading Down 1.3%

NYSE:CVS opened at $66.98 on Monday. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The business’s 50 day moving average is $66.96 and its two-hundred day moving average is $59.06. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51. The company has a market cap of $84.73 billion, a PE ratio of 18.30, a P/E/G ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The business had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the business posted $1.31 EPS. The business’s revenue was up 7.0% on a year-over-year basis. On average, analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.97%. CVS Health’s dividend payout ratio is 63.48%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.